Literature DB >> 28734448

Alternative Strategy for Biventricular Assist Device in an Infant With Hypertrophic Cardiomyopathy.

John C Dykes1, Olaf Reinhartz2, Christopher S Almond3, Vamsi Yarlagadda3, Jenna Murray4, David N Rosenthal3, Katsuhide Maeda2.   

Abstract

We report an infant with hypertrophic cardiomyopathy who underwent biventricular assist device placement with two 15-mL Berlin Heart EXCOR pediatric ventricular assist devices using an alternative atrial cannulation strategy. The systemic circulation was supported by left atrium (LA) to aorta cannulation. The LA was accessed through the right atrium by extending a 6-mm EXCOR cannula with a Gore-Tex graft connected to an atrial septal defect. The pulmonary circulation was supported with cannulation of the right atrium to pulmonary artery. This alternative cannulation strategy facilitated effective biventricular support and may be applicable to other patients with hypertrophic or restrictive physiology.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28734448     DOI: 10.1016/j.athoracsur.2017.02.069

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  2019 EACTS Expert Consensus on long-term mechanical circulatory support.

Authors:  Evgenij V Potapov; Christiaan Antonides; Maria G Crespo-Leiro; Alain Combes; Gloria Färber; Margaret M Hannan; Marian Kukucka; Nicolaas de Jonge; Antonio Loforte; Lars H Lund; Paul Mohacsi; Michiel Morshuis; Ivan Netuka; Mustafa Özbaran; Federico Pappalardo; Anna Mara Scandroglio; Martin Schweiger; Steven Tsui; Daniel Zimpfer; Finn Gustafsson
Journal:  Eur J Cardiothorac Surg       Date:  2019-08-01       Impact factor: 4.191

2.  Berlin Excor Cannulation of Left Atrial Appendage in Left Ventricular Restrictive Physiology: A Novel Bailout Strategy.

Authors:  Gamal M Marey; Sameh M Said; Rebecca Ameduri; Marie E Steiner; Michael Bowler; Ashley Loomis; Subin Jang; Massimo Griselli
Journal:  ASAIO J       Date:  2021-09-01       Impact factor: 3.826

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.